Home LiteratureArticle Details
PMID: 53789 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Surface markers and prognostic factors in acute lymphoblastic leukemia.

The New England journal of medicine ·Vol. 294 ·No. 5 ·1976-01-29 ·Pages 245-8

Tsukimoto I, Wong KY, Lampkin BC

Abstract

We investigated the surface markers on lymphoblasts from 37 patients with acute lymphoblastic leukemia. Spontaneous rosette formation with sheep erythrocytes (E rosettes) identified T cells and the presence of surface immunoglobulin identified B cells. Eight patients had T-marker lymphoblasts; 28 had no markers (null lymphoblasts), and one patient had B-marker lymphoblasts. The eight patients with T-marker acute lymphoblastic leukemia had massive leukemic infiltration, frequently a mediastinal mass, and a poor prognosis. The T-marker lymphoblasts had a weak or negative periodic acid-Schiff reaction and a very low antigenic stimulation to allogeneic lymphocytes. The association of T-marker lymphoblasts and some of the conventional poor-risk factors appears to be reliable in predicting a poor prognosis.

MeSH Terms
B-Lymphocytes/immunology Bone Marrow Cells Child Female Humans Immune Adherence Reaction Leukemia, Lymphoid/diagnosis,immunology Male Mitotic Index Periodic Acid Prognosis Receptors, Antigen, B-Cell/analysis Staining and Labeling T-Lymphocytes/cytology,immunology
Chemicals
Receptors, Antigen, B-Cell Periodic Acid
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tsukimoto I
Wong K Y
Lampkin B C
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1976-01-29
Pages
245-8
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com